Complex Coronary Bifurcation Revascularization by Means of Very Minimal Crushing and Ultrathin Biodegradable Polymer DES: Feasibility and 1-Year Outcomes of the "Nano-Crush" Technique.

Gianluca Rigatelli,Fabio Dell'Avvocata,Marco Zuin,Dobrin Vassiliev,Alberto Mazza,Huy D. Dinh
DOI: https://doi.org/10.1016/j.carrev.2016.07.003
2016-01-01
Cardiovascular Revascularization Medicine
Abstract:Aim: To assess feasibility and 1-year outcomes of ultrathin biodegradable polymer double stenting using a very minimal crushing (nano-crush technique) in a series of patients with large (>= 2.5 mm) complex coronary bifurcation.Methods: From January 2015 to June 2016, patients referred for large (>= 2.5 mm) complex coronary bifurcation percutaneous coronary interventions (PCI) were enrolled to receive Orsiro (Biotronik Inc., Bulack, Switzerland) double stenting using a very minimal crush technique (nano-crush). Per our institutional protocol, follow-up was conducted by physical examination at 1, 6, 12 month and yearly whereas angiographic control was eventually scheduled at 6-8months on the basis of symptoms recurrence or/and positive induced ischemia tests.Results: Fifty-two patients (15 females mean age 77.2 +/- 6.2 years) were enrolled. Mean angles between main branch and side branch were 63.6 +/- 21.3 degrees. The mean diameter and length of implanted stents were 3.8 +/- 0.4 mm and 27.1 +/- 8.7 mm in main branch and 2.8 +/- 0.3 mm and 22.1 +/- .7.1 mm in side branch. Immediate successwas 100%. Clinical follow-upwas available for 100% of patients: at amean follow-up of 12.0 +/- 2.6months, no patient death, or acute myocardial infarction or target vessel revascularization were observed. Angiographic follow-up was available in 25/52 patients (48%) at a mean time from the procedure of 7.2 +/- 0.5 months and showed no significant angiographic restenosis.Conclusions: The revascularization of complex large (>= 2.5mm) coronary bifurcation disease using the nano-crush technique and the ultrathin polymer biodegradable stent appeared feasible in our small study with promising 1 year outcomes. (C) 2016 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?